| Paranasal Sinus Squamous Cell Carcinoma studied in …STUDIED_INderived11 of 11show fewer |
|---|
| → studied in | NCT05172245Phase 1 · recruiting Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 11 trials mapped (6 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07156227Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 11 trials mapped (6 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04576091Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 11 trials mapped (6 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06662058NA · recruiting Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation · condition mapped CURATED_BROADER · 11 trials mapped (6 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03370276Phase 1/Phase 2 · completed Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma · condition mapped ALIAS · 11 trials mapped (6 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06636734Phase 2 · recruiting Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial · condition mapped CURATED_BROADER · 11 trials mapped (6 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03468218Phase 2 · active not recruiting Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer · condition mapped ONTOLOGY_EXACT · 11 trials mapped (6 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03381183Phase 1 · completed IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 11 trials mapped (6 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06865313completed Functional Evaluation After Maxillectomy and Scapular Free Flap Reconstruction · condition mapped ONTOLOGY_EXACT · 11 trials mapped (6 active) | — | — | Maxillary Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03032250NA · completed Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer · condition mapped ONTOLOGY_EXACT · 11 trials mapped (6 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01267240Phase 2 · terminated Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 11 trials mapped (6 active) | — | — | Paranasal Sinus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |